Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy
Clinical trial NCT03762564 · COMPLETED
Trial details
- NCT number
- NCT03762564
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2022-07-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.